Iradimed Corp. (IRMD) Tops Q4 EPS by 3c

Iradimed Corp. (NASDAQ: IRMD) reported Q4 EPS of $0.22, $0.03 better than the analyst estimate of $0.19. Revenue for the quarter came in at $8.8 million versus the consensus estimate of $8.8 million.

GUIDANCE:

Iradimed Corp. sees Q1 2016 EPS of $0.17-$0.18, versus the consensus of $0.18. Iradimed Corp. sees Q1 2016 revenue of $9.0-9.1 million, versus the consensus of $9.1 million.

Iradimed Corp. sees FY2016 EPS of $0.83-$0.85, versus the consensus of $0.83. Iradimed Corp. sees FY2016 revenue of $39-40 million, versus the consensus of $39.2 million.

For earnings history and earnings-related data on Iradimed Corp. (IRMD) click here.

You May Also Be Interested In

• FedEx falls 4% as CY2026 profit forecast misses expectations despite Q4 beat
• Citrini flags overheating concerns as leverage, chip rally weigh on KOSPI
• Nike names former Pfizer CFO David Denton as new finance chief